Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0532 | 0.4752 | 0.4276 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.05 | 0.4361 | 0.5834 |
Echinococcus granulosus | aurora kinase A | 0.0905 | 0.9446 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.028 | 0.1592 | 0.0745 |
Loa Loa (eye worm) | AUR protein kinase | 0.0905 | 0.9446 | 1 |
Echinococcus granulosus | serine:threonine protein kinase 12 B | 0.0905 | 0.9446 | 0.5 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.0285 | 0.1644 | 0.2199 |
Mycobacterium ulcerans | polyketide synthase Pks9 | 0.0331 | 0.2228 | 0.2981 |
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.0748 | 0.7476 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.05 | 0.4361 | 0.581 |
Mycobacterium tuberculosis | Polyketide synthetase MbtC (polyketide synthase) | 0.0172 | 0.0229 | 0.0306 |
Toxoplasma gondii | aurora kinase | 0.0905 | 0.9446 | 1 |
Entamoeba histolytica | serine/threonine protein kinase 6, putative | 0.0905 | 0.9446 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0905 | 0.9446 | 0.5 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks15 | 0.0202 | 0.061 | 0.0817 |
Loa Loa (eye worm) | AUR protein kinase | 0.0905 | 0.9446 | 1 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.05 | 0.4361 | 0.5834 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.0532 | 0.4752 | 0.6337 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.0485 | 0.4168 | 0.5576 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.0902 | 0.9416 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0905 | 0.9446 | 0.5 |
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0532 | 0.4752 | 0.6357 |
Plasmodium falciparum | serine/threonine protein kinase, putative | 0.0905 | 0.9446 | 0.5 |
Giardia lamblia | Aurora kinase | 0.0905 | 0.9446 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0905 | 0.9446 | 0.5 |
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.0485 | 0.4168 | 0.5576 |
Loa Loa (eye worm) | fatty acid synthase | 0.0494 | 0.4277 | 0.391 |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.0532 | 0.4752 | 0.6337 |
Mycobacterium ulcerans | polyketide synthase | 0.05 | 0.4361 | 0.5834 |
Loa Loa (eye worm) | AUR protein kinase | 0.0905 | 0.9446 | 1 |
Echinococcus multilocularis | serine:threonine protein kinase 12 B | 0.0905 | 0.9446 | 0.5 |
Trypanosoma brucei | aurora B kinase | 0.0905 | 0.9446 | 0.5 |
Echinococcus multilocularis | aurora kinase A | 0.0905 | 0.9446 | 0.5 |
Onchocerca volvulus | 0.0871 | 0.9025 | 0.9285 | |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0403 | 0.3131 | 0.4188 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.0748 | 0.7476 | 1 |
Entamoeba histolytica | protein kinase , putative | 0.0905 | 0.9446 | 0.5 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE | 0.0331 | 0.2228 | 0.2941 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0532 | 0.4752 | 0.6357 |
Schistosoma mansoni | protein kinase | 0.0905 | 0.9446 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0905 | 0.9446 | 0.5 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.0403 | 0.3131 | 0.4155 |
Trichomonas vaginalis | AGC family protein kinase | 0.0905 | 0.9446 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0841 | 0.8643 | 0.9054 |
Entamoeba histolytica | serine/threonine- protein kinase 6 , putative | 0.0905 | 0.9446 | 0.5 |
Entamoeba histolytica | serine/threonine- protein kinase 6, putative | 0.0905 | 0.9446 | 0.5 |
Brugia malayi | AMP-binding enzyme family protein | 0.0468 | 0.3948 | 0.3948 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0905 | 0.9446 | 0.5 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0532 | 0.4752 | 0.6357 |
Brugia malayi | serine/threonine-protein kinase 6 | 0.0905 | 0.9446 | 0.9446 |
Entamoeba histolytica | protein kinase, putative | 0.0905 | 0.9446 | 0.5 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.0325 | 0.2149 | 0.1101 |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.0417 | 0.3311 | 0.443 |
Mycobacterium ulcerans | fatty acid synthase Fas | 0.0157 | 0.0042 | 0.0056 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.0403 | 0.3131 | 0.4188 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.05 | 0.4361 | 0.5834 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.0532 | 0.4752 | 0.6357 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.05 | 0.4361 | 0.4361 |
Mycobacterium ulcerans | thioesterase | 0.0417 | 0.3311 | 0.443 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.05 | 0.4361 | 0.581 |
Leishmania major | protein kinase, putative | 0.0905 | 0.9446 | 0.5 |
Plasmodium vivax | serine/threonine protein kinase 6, putative | 0.0905 | 0.9446 | 0.5 |
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.0417 | 0.3311 | 0.4398 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsE | 0.0331 | 0.2228 | 0.2981 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.0532 | 0.4752 | 0.6337 |
Mycobacterium ulcerans | thioesterase TesA | 0.0417 | 0.3311 | 0.443 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.0532 | 0.4752 | 0.6357 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0468 | 0.3948 | 0.3521 |
Brugia malayi | serine/threonine protein kinase 6 | 0.0905 | 0.9446 | 0.9446 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.05 | 0.4361 | 0.5834 |
Mycobacterium tuberculosis | Probable fatty acid synthase Fas (fatty acid synthetase) | 0.0157 | 0.0042 | 0.0056 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.05 | 0.4361 | 0.5834 |
Brugia malayi | serine/threonine kinase 12 | 0.0905 | 0.9446 | 0.9446 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0356 | 0.2547 | 0.1586 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0468 | 0.3948 | 0.528 |
Mycobacterium ulcerans | polyketide synthase | 0.0532 | 0.4752 | 0.6357 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.05 | 0.4361 | 0.5834 |
Trypanosoma cruzi | aurora B kinase, putative | 0.0905 | 0.9446 | 0.5 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.0748 | 0.7476 | 1 |
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.0748 | 0.7476 | 1 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks1 | 0.036 | 0.2588 | 0.3461 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.05 | 0.4361 | 0.5834 |
Entamoeba histolytica | protein kinase, putative | 0.0905 | 0.9446 | 0.5 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.0409 | 0.3214 | 0.4299 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -5.874 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.805 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.801 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.653 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.545 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.409 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.35 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.331 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.168 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.112 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.046 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.847 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.